COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID-19 infection and hospitalization rate in Iranian multiple sclerosis patients: What we know by May 2021

Published:2022-01 Issue: Volume:57 Page:103335
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Naghavi Saba,Kavosh Aryan,Adibi Iman,Shaygannejad Vahid,Arabi Sina,Rahimi Maryam,Mazaheri Shahbanoo,Ashtari Fereshteh

Funder

Isfahan University of Medical Sciences

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference41 articles.

1. National Multiple Sclerosis Society, 2021. What is MS. https://www.nationalmssociety.org/What-is-MS/Types-of-MS/ (Accessed 19 Octobr 2021).

2. World Health Organization, 2020. news. https://www.who.int/news/item/27-04-2020-who-timeline-covid-19/ (accessed 27 April 2020).

3. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis;Booth;PLoS One,2021

4. MS: immunosuppression is passé;Brod;Mult. Scler. Relat. Disord.,2020

5. The first 12 months of COVID-19: a timeline of immunological insights;Carvalho;Nat. Rev. Immunol.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review;International Journal of Molecular Sciences;2023-05-25

2. Multiple sclerosis and COVID-19: A retrospective study in Iran;PLOS ONE;2023-03-23

3. The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study;Multiple Sclerosis and Related Disorders;2022-09

4. Predictive modeling for COVID-19 readmission risk using machine learning algorithms;BMC Medical Informatics and Decision Making;2022-05-20

5. Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies;Multiple Sclerosis and Related Disorders;2022-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3